<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03302169</url>
  </required_header>
  <id_info>
    <org_study_id>PR(AG)330/2016</org_study_id>
    <nct_id>NCT03302169</nct_id>
  </id_info>
  <brief_title>Trial to Compare Urinary Continence Recovery After Robotic Radical Prostatectomy With or Without Rhabdosphincter Reconstruction.</brief_title>
  <acronym>RHABDO-PROST</acronym>
  <official_title>Prospective Randomized Controlled Trial to Compare Early Urinary Continence Recovery After Robotic Assisted Radical Prostatectomy With or Without Posterior Rhabdosphincter Reconstruction.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari Vall d'Hebron Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitari Vall d'Hebron Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective randomized controlled trail to assess early urinary continence recovery
      rates after robotic assisted radical prostatectomy when a posterior rhabdosphincter
      reconstruction is performed or not. A hundred forty-six patients with clinically localized
      and histological confirmed prostate cancer will be enrolled. Continence recovery is defined
      in the present study as declared urinary continence (absence of incontinence episodes) in the
      physician interview as no pad use. Continence rates will be explored also by EPIC, ICIQ-SF,
      IPSS questionnaires 1, 6 and 12 months after the procedure. The sexual function as the
      secondary objective will be assessed by SHIM questionnaire.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>This is a prospective randomized controlled trial to assess early urinary continence recovery rates after robotic assisted radical prostatectomy when a posterior rhabdosphincter reconstruction is performed or not.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients using 0-1 PAD/d (EPIC-26 question_3) at 1st monthNumber of patients using 0-1 PAD/d (EPIC-26 question_3) at 1st month</measure>
    <time_frame>1 month after surgery</time_frame>
    <description>Absence of urinary incontinence (number of PADs/d)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients using 0-1 PAD/d (EPIC-26 question_3) at 6th month</measure>
    <time_frame>6 months after surgery</time_frame>
    <description>Absence of urinary incontinence (number of PADs/d)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>early urinary recovery quantification in Grams (PAD-test 24h)</measure>
    <time_frame>one day before catheter removal, 2 weeks before and 1 month before</time_frame>
    <description>PAD-test during the first month after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients using 0-1 PAD/d (EPIC-26 question_3) at 12th month</measure>
    <time_frame>12 months after surgery</time_frame>
    <description>Absence of urinary incontinence (number of PADs/d)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Erectile function</measure>
    <time_frame>1, 6 and 12 months</time_frame>
    <description>SHIM assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life I: urinary and bowel function</measure>
    <time_frame>1, 6 and 12 months</time_frame>
    <description>EPIC-26 urinary and digestive function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life II: urinary function</measure>
    <time_frame>1, 6 and 12 months</time_frame>
    <description>ICIQ-SF assessment of urinary function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life III: urinary function</measure>
    <time_frame>1, 6 and 12 months</time_frame>
    <description>IPSS assessment of urinary function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oncological outcome: Biochemical free-recurrence status</measure>
    <time_frame>1, 6 and 12 months</time_frame>
    <description>serum PSA assessment. Biochemical free-recurrence status = PSA &lt;0.2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anatomopathological parameters: Surgical margins</measure>
    <time_frame>1 month</time_frame>
    <description>Surgery margins in prostatectomy specimens</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anatomopathological parameters: pTNM classification</measure>
    <time_frame>1 month</time_frame>
    <description>Pathological pTNM in prostatectomy specimens</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">146</enrollment>
  <condition>Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>Posterior Rhabdosphincter Reconstruction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in who posterior rhabdosphincter reconstruction is performed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Technique</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in who posterior rhabdosphincter reconstruction is NOT performed, Standard technique.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radical prostatectomy with posterior rhabdosphincter reconstruction</intervention_name>
    <description>To suture the Denonvilliers fascia and bladder to the median dorsal raphe according to Rocco technique.</description>
    <arm_group_label>Posterior Rhabdosphincter Reconstruction</arm_group_label>
    <other_name>Rocco reconstruction technique</other_name>
    <other_name>Posterior reconstruction</other_name>
    <other_name>Rocco Stitch</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radical prostatectomy without posterior rhabdosphincter reconstruction</intervention_name>
    <description>Standard technique with a running suture to perform the urethrovesical anastomosis</description>
    <arm_group_label>Standard Technique</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histological confirmation of prostate cancer

          -  Localized or locally advanced prostate cancer

          -  Informed consent signed

        Exclusion Criteria:

          -  Presence of urinary incontinence prior to the procedure

          -  Previous radiation therapy of the prostate or pelvis

          -  Presence of any prostatic surgery prior to the procedure

          -  Prior medical history of psychiatric diseases or drug addiction

          -  Any condition that contraindicates a radical prostatectomy
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juan Morote, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Vall d'Hebron</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lucas Regis, PhD</last_name>
    <phone>+34 934 89 30 00</phone>
    <phone_ext>6370</phone_ext>
    <email>lregis@vhebron.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Juan Morote, PhD</last_name>
    <phone>+34 934 89 30 00</phone>
    <phone_ext>6370</phone_ext>
    <email>jmorote@vhebron.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Universitari Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucas Regis, PhD</last_name>
      <phone>+34 934 89 30 00</phone>
      <phone_ext>6370</phone_ext>
      <email>lregis@vhebron.net</email>
    </contact>
    <investigator>
      <last_name>Juan Morote, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacques Planas, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lucas Regis, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana Celma, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aina Salazar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 15, 2017</study_first_submitted>
  <study_first_submitted_qc>September 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 5, 2017</study_first_posted>
  <last_update_submitted>November 20, 2017</last_update_submitted>
  <last_update_submitted_qc>November 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prostate Cancer</keyword>
  <keyword>Urinary incontinence</keyword>
  <keyword>Radical prostatectomy</keyword>
  <keyword>Rhabdosphincter</keyword>
  <keyword>Robotic Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

